Protein Kinase C θ Plays a Fundamental Role in Different Types of Chronic Colitis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Gastroenterology

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/J.GASTRO.2007.11.005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial NEMO links innate immunity to chronic intestinal inflammation

  2007cited by this paper
• TLR Ligands Act Directly upon T Cells to Restore Proliferation in the Absence of Protein Kinase C-θ Signaling and Promote Autoimmune Myocarditis1

  2007cited by this paper
• The fundamental basis of inflammatory bowel disease.

  2007cited by this paper
• Repertoire of the αβ T‐cell receptor in the intestine

  2007cited by this paper
• The Critical Role of Protein Kinase C-θ in Fas/Fas Ligand-Mediated Apoptosis1

  2007cited by this paper
• IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.

  2006cited by this paper
• Proteasome-mediated degradation of IκBα and processing of p105 in Crohn disease and ulcerative colitis

  2006cited by this paper
• IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis

  2006cited by this paper
• PKC-θ-Deficient Mice Are Protected from Th1-Dependent Antigen-Induced Arthritis

  2006cited by this paper
• Involvement of GATA3 in Protein Kinase C θ‐induced Th2 cytokine expression

  2006cited by this paper
• Resistance to Experimental Autoimmune Encephalomyelitis and Impaired IL-17 Production in Protein Kinase Cθ-Deficient Mice

  2006cited by this paper
• Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases

  2006cited by this paper
• IL-7 promotes T cell proliferation through destabilization of p27Kip1

  2006cited by this paper
• Colostomy: formation and closure

  2006cited by this paper
• Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

  2006cited by this paper
• Defects in mucosal immunity leading to ulcerative colitis

  2005cited by this paper
• Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides

  2005cited by this paper
• Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation.

  2005cited by this paper
• Protein Kinase Cθ Controls Th1 Cells in Experimental Autoimmune Encephalomyelitis1

  2005cited by this paper
• Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota

  2005cited by this paper
• SAP Regulates TH2 Differentiation and PKC-θ-Mediated Activation of NF-κB1

  2004cited by this paper
• SPAK kinase is a substrate and target of PKCθ in T‐cell receptor‐induced AP‐1 activation pathway

  2004cited by this paper
• Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function

  2004cited by this paper
• A Contribution of Mouse Dendritic Cell–Derived IL-2 for NK Cell Activation

  2004cited by this paper
• Protein Kinase C (cid:2) Is Critical for the Development of In Vivo T Helper (Th)2 Cell But Not Th1 Cell Responses

  2004cited by this paper
• Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation.

  2004cited by this paper
• Protein kinase C‐θ (PKCθ): it's all about location, location, location

  2003cited by this paper
• Protein Kinase C (cid:2) Affects Ca 2 (cid:3) Mobilization and NFAT Cell Activation in Primary Mouse T Cells

  2003cited by this paper
• Immune Networks in Animal Models of Inflammatory Bowel Disease

  2003cited by this paper
• Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.

  2002cited by this paper
• Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function

  2002cited by this paper
• The role of Th1/Th2 polarization in mucosal immunity

  2002cited by this paper
• Protein kinase C-θ: signaling from the center of the T-cell synapse

  2002cited by this paper
• The immunological synapse.

  2001cited by this paper
• PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes

  2000cited by this paper
• Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

  2000cited by this paper
• Alteration of Interleukin 4 Production Results in the Inhibition of T Helper Type 2 Cell–Dominated Inflammatory Bowel Disease in T Cell Receptor α Chain–Deficient Mice

  1999cited by this paper
• The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice.

  1999cited by this paper
• Suppressive Role of B Cells in Chronic Colitis of  T Cell Receptor α Mutant Mice

  1997cited by this paper
• Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐Tolerance

  1995cited by this paper
• T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice

  1995cited by this paper
• Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin‐2‐deficient colitis

  1995cited by this paper
• The Orphan Nuclear Receptor ROR g t Directs the Differentiation Program of Proinflammatory IL-17 + T Helper Cells

  year unknowncited by this paper

• Inhibition of PKCθ Abrogates CD8+ T Cell-Mediated Neurotoxicity in Murine Cerebral Malaria

  2025cites this paper
• Discovery of a novel series of selective macrocyclic PKCTheta inhibitors.

  2024cites this paper
• Anti-inflammatory effects of anemonin on acute ulcerative colitis via targeted regulation of protein kinase C-θ

  2022cites this paper
• A cell-based drug delivery platform for treating central nervous system inflammation

  2021cites this paper
• Biological Analyses-Derived Translational Findings in the T Cell Receptor Alpha Chain Knockout Mouse as an Experimental Model for Ulcerative Colitis

  2021cites this paper
• Identification of good and bad fragments of tricyclic triazinone analogues as potential PKC-θ inhibitors through SMILES–based QSAR and molecular docking

  2020cites this paper
• Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis.

  2019cites this paper
• Missense mutation in PRKCQ is associated with Crohn's disease

  2019cites this paper
• Smoking affects gene expression in blood of patients with ischemic stroke

  2019cites this paper
• Targeting early PKCθ‐dependent T‐cell infiltration of dystrophic muscle reduces disease severity in a mouse model of muscular dystrophy

  2018cites this paper
• The role of galectin-4 in physiology and diseases

  2016cites this paper
• Vasoactive intestinal peptide suppresses macrophage‐mediated inflammation by downregulating interleukin‐17A expression via PKA‐ and PKC‐dependent pathways

  2015cites this paper
• Protein kinase Cθ: the pleiotropic T-cell signalling intermediate.

  2014cites this paper
• From Innate to Adaptive Immune Response in Muscular Dystrophies and Skeletal Muscle Regeneration: The Role of Lymphocytes

  2014cites this paper
• Selective protein kinase Cθ (PKCθ) inhibitors for the treatment of autoimmune diseases.

  2014cites this paper
• Rational design, synthesis and QSAR study of vasorelaxant active 3-pyridinecarbonitriles incorporating 1H-benzimidazol-2-yl function.

  2013cites this paper
• Th22 and related cytokines in inflammatory and autoimmune diseases

  2013cites this paper
• Insights from Recent Advances in Animal Models of Inflammatory Bowel Disease

  2013cites this paper
• Animal Models of Inflammatory Bowel Disease for Drug Discovery

  2013cites this paper
• Design and optimization of selective protein kinase C θ (PKCθ) inhibitors for the treatment of autoimmune diseases.

  2013cites this paper
• Protein kinase C-theta inhibitors: a novel therapy for inflammatory disorders.

  2012cites this paper
• Animal models of inflammatory bowel disease.

  2012cites this paper
• The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice.

  2012cites this paper
• Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cells

  2012influential citation
• Expression of Protein Kinase C Family in Human Hepatocellular Carcinoma

  2010cites this paper
• Cytokines and Chemokines in Mucosal Homeostasis

  2010cites this paper
• Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles.

  2009cites this paper
• The genetics of Crohn's disease.

  2009cites this paper
• PKC inhibitors: potential in T cell-dependent immune diseases.

  2009cites this paper
• IL-17/23, potential targets for Crohn’s disease

  2009cites this paper
• Second generation 4-(4-methyl-1H-indol-5-ylamino)-2-phenylthieno[2,3-b]pyridine-5-carbonitrile PKCtheta inhibitors.

  2009cites this paper
• Optimization of 5-phenyl-3-pyridinecarbonitriles as PKCtheta inhibitors.

  2009cites this paper
• Protein kinase C isozymes as potential therapeutic targets in immune disorders

  2008cites this paper
• G Protein–Coupled Receptor Connectivity to NF-κB in Inflammation and Cancer

  2008cites this paper
• Roles of galectins in inflammatory bowel disease.

  2008cites this paper